Prostate-Specific Antigen
Research from Uniformed Services University of the Health Sciences, Health Science Center in the area of prostate-specific antigen published
Published in Cancer Weekly, June 3rd, 2008
According to a study from the United States, "Hormonal therapy (HT) is the current mainstay of systemic treatment for prostate specific antigen (PSA) only recurrence (PSAR), however, there is virtually no published literature comparing HT to observation in the clinical setting. The goal of this study was to examine the Department of Defense Center for Prostate Disease Research observational database to compare clinical outcomes in men who experienced PSAR after radical prostatectomy by early versus delayed use of HT and by a risk stratified approach."
"Of 5,382 men in the database who underwent primary radical prostatectomy (RP), 4,967 patients were treated in the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2008-06-03)
More Articles from Cancer Weekly
- University Hospitals of Cleveland
Study: Patients 75 years and older with brain tumors may benefit from more aggressive treatment - World Journal of Gastroenterology
A new change in the chromosome of patients with esophageal squamous cell carcinoma - World Journal of Gastroenterology
A potential route for human tumor gene therapy - World Journal of Gastroenterology
Can pathological techniques help identify primary colorectal signet ring cell carcinoma? - Cancer Gene Therapy
Research from Jikei University, Medical Department in the area of cancer gene therapy published - Cancer Gene Therapy
Research reports from Shandong University provide new insights into cancer gene therapy - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
